The wire › SEC Form 8-K
Qualigen Therapeutics, Inc. QLGN
Filed with the SEC on May 19, 2025. Reported event date May 19, 2025.
- Business address
- California, CA
- State
- California
- Incorporated in
- Delaware
- Industry
- Manufacturing (SIC 2834)
- SEC CIK
- 1460702
- Accession number
- 0001641172-25-011530
Items reported in this filing
- Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
An exchange told the company it does not meet a continued-listing rule, or the company is delisting or moving its listing: Form 8-K Item 3.01. Many of these are compliance notices with time to fix, not closures.
- Item 7.01 Regulation FD Disclosure
- Item 9.01 Financial Statements and Exhibits
Other entries on the wire for this company
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing